3min snip

ACQ2 by Acquired cover image

The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

ACQ2 by Acquired

NOTE

Exploring Belief, Data Accumulation, and Weight Loss Impact on Product Recognition

Believing in a product and allowing it time to mature can lead to success, especially when backed by significant positive data. The slow accumulation of positive data over decades can boost recognition and acceptance of a product. The tipping point for widespread adoption may occur when about 15% of the population becomes aware of the product. In the case of GOP one medicines, the gradual accumulation of positive data, along with the ability to save lives and improve cardiovascular health, contributed to their success. The impact of weight loss as a result of the product is crucial in garnering attention and recognition since it is relatable and visible to individuals, providing quick and tangible results. The immediate and noticeable effects on hunger and appearance can significantly reinforce the belief in the product's efficacy and help in widespread recognition and adoption.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode